🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 375558103
- Market Cap
- Large Cap
Business: Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North and South America, Europe and Asia Pacific.
Notes: Oct 23, 202-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to acquire Immunomedics, Inc. (Nasdaq: IMMU) for approximately $21 billion in the aggregate.
Company Contact
- CEO
- Daniel O'Day
- CFO
- Andrew Dickinson
- Headquarters
- 333 Lakeside Drive, Foster City, CA 94404
- Phone
- 650-574-3000
- Fax
- 650-522-5853
- Investor Relations
- Andrew Dickinson · 650-574-0862 · investor_relations@gilead.com